Gulf Coast

Resilience System

Main menu


You are here

Home

Medical Testing

Moderate COVID-19 increasses risk of blood cloots; high-dose blood thinner can prevent clots--study

Mon, 2021-10-11 17:48 — mike kraft
Risk of dangerous blood clots linked to moderate COVID-19; high-dose blood thinner can prevent clots The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that have yet to be certified by peer review. Nancy Lapid Reuters
Country / Region Tags: 
Europe
Global
United States
General Topic Tags: 
COVID-19
Data
Medical Testing
Contagion
Disease
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

AstraZeneca antibody cocktail study shows success treating COVID-19

Mon, 2021-10-11 11:41 — mike kraft
AstraZeneca antibody cocktail study shows success treating COVID-19 AstraZeneca's antibody cocktail against COVID-19, which has proven to work as a preventative shot in the non-infected, was also shown to save lives and prevent severe disease when given as treatment within a week of first symptoms. Ludwig Burger,Yadarisa Shabong,Sachin Ravikumar Reuters
Country / Region Tags: 
Global
Sweden
United States
General Topic Tags: 
COVID-19
Data
Medical Testing
Public Health
Contagion
Drought
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Situation Report

Merck formally requests FDA authorization for COVID-19 antiviral pill

Mon, 2021-10-11 09:42 — mike kraft
Merck requests FDA authorization for COVID-19 antiviral pill Merck said on Monday that it has requested authorization from the Food and Drug Administration (FDA) for its antiviral COVID-19 pill. Joseph Choi TheHill
Country / Region Tags: 
Australia
Global
South Korea
Thailand
United States
General Topic Tags: 
COVID-19
Medical Testing
Public Health
Contagion
Disease
Government
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Situation Report

Delta does not appear to make children sicker; Secondary immune response stronger after infection than after shot--studies

Fri, 2021-10-08 18:22 — mike kraft
Delta does not appear to make children sicker; Secondary immune response stronger after infection than after shot The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that have yet to be certified by peer review. Nancy Lapid Reuters
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Data
Medical Testing
Public Health
Vaccinations
Contagion
Disease
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

EU ambassador says Russia delays EMA Sputnik V vaccine inspections - media report

Fri, 2021-10-08 10:52 — mike kraft
EU envoy says Russia delays EMA Sputnik V vaccine inspections - media Russia has repeatedly delayed inspections by the European Medicines Agency (EMA) necessary for the certification of its Sputnik V COVID-19 vaccine in the European Union, the EU's ambassador to Moscow was quoted as saying on Friday. Reuters Staff U.S.

MOSCOW (Reuters) -  ...

Country / Region Tags: 
Eastern Europe
Europe
General Topic Tags: 
COVID-19
Medical Testing
Vaccinations
Contagion
Disease
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Situation Report

Merck antiviral drug molnupiravir has not shown "significant efficacy" against COVID-19-- Indian officials

Fri, 2021-10-08 10:32 — mike kraft
Merck drug less effective against moderate COVID -India regulatory source Merck & Co's experimental antiviral drug molnupiravir has not shown "significant efficacy" against moderate COVID-19, a source with the Drug Controller General of India said. Neha Arora Reuters
Country / Region Tags: 
Global
India
United States
General Topic Tags: 
COVID-19
Medical Testing
Contagion
Disease
Government
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Situation Report

Pfizer asks US to allow COVID shots for kids ages 5 to 11

Thu, 2021-10-07 08:49 — mike kraft
Pfizer asks US to allow COVID shots for kids ages 5 to 11 Pfizer asked the U.S. government Thursday to allow use of its COVID-19 vaccine in children ages 5 to 11 -- and if regulators agree, shots could begin within a matter of weeks. Many parents and pediatricians are clamoring for protection for children younger than 12, today’s age cutoff for the vaccine made by Pfizer and its German partner BioNTech. AP NEWS
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Medical Testing
Vaccinations
Contagion
Demographics
Disease
Government
Health
Pandemics
Research
Science
Problem, Solution, SitRep, or ?: 
Situation Report

Los Angeles officials approve one of strictest US vaccination mandates, other mandates likely

Wed, 2021-10-06 17:37 — mike kraft
Los Angeles OKs one of strictest US vaccination mandates LOS ANGELES (AP) — Los Angeles leaders on Wednesday approved one of the nation's strictest vaccine mandates — a sweeping measure that requires the shots for everyone entering bars, restaurants, nail salons, gyms or even a Lakers game. AP NEWS

...

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Disease Prevention
Medical Testing
Public Attitudes
Public Health
Social behavior
Vaccinations
Cities
Contagion
Disease
Government
Health
Pandemics
Politics
Problem, Solution, SitRep, or ?: 
Situation Report

White House moves to quadruple rapid testing supply by December

Wed, 2021-10-06 10:31 — mike kraft
White House moves to quadruple rapid testing supply by December The White House said Wednesday that the country's supply of at-home rapid COVID-19 tests is on track to quadruple by December, amid a flurry of new announcements. Peter Sullivan TheHill
Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Medical Testing
Public Health
Contagion
Disease
Government
Health
Pandemics
Policy
Problem, Solution, SitRep, or ?: 
Situation Report

Sweden pauses use of Moderna vaccine for those 30 and under

Wed, 2021-10-06 10:02 — mike kraft
Sweden pauses use of Moderna COVID vaccine for younger age groups Sweden will pause the use of Moderna's COVID-19 vaccine for people born 1991 and later after reports of possible rare side effects, such as myocarditis, the Swedish health agency said on Wednesday. Reuters Reuters
Country / Region Tags: 
Europe
Sweden
General Topic Tags: 
COVID-19
Data
Medical Testing
Public Health
Vaccinations
Complexity
Disease
Government
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Situation Report

Pages

Subscribe to Medical Testing
howdy folks
Page loaded in 0.600 seconds.